HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODY-RESPONSE IN JAPANESE CHILDREN WITH BONE-MARROW TRANSPLANTATION

被引:2
作者
OHIZUMI, Y
SUZUKI, H
NUMAZAKI, Y
IMAIZUMI, M
KOISUMI, Y
SUZUKI, H
TADA, K
MINEGISHI, M
TSUCHIYA, S
KONNO, T
机构
[1] TOHOKU UNIV, SCH MED, DEPT PEDIAT, SENDAI, MIYAGI 98077, JAPAN
[2] TOHOKU UNIV, INST DEV AGING & CANC, DEPT PEDIAT ONCOL, SENDAI, MIYAGI 98077, JAPAN
关键词
CYTOMEGALOVIRUS; BONE MARROW TRANSPLANTATION; NEUTRALIZING ANTIBODY; INTRAVENOUS GAMMA-GLOBULIN;
D O I
10.1620/tjem.174.11
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thirty-two children with bone barrow transplantation (BMT) received intravenous injections of gammaglobulin (IVIG) with a high titer of neutralizing (NT) antibody against human cytomegalovirus (HCMV) (200 mg/kg/week) from 1 week before to 4 months after transplantation. NT antibody titers before BMT and the highest levels in serial determinations conducted after BMT were compared for each patient. They mere classified into three groups according to the antibody response: primary HCMV infection as group I, endogenous reactivation or external reinfection as group II, and indeterminable cases as group III. Two (6.3%) out of 32 patients examined had BMT-associated primary HCMV infections, but did not show any clinical symptoms. Significant changes in clinical parameters mere also lacking in all the other 30 patients, independent of whether they shed viruses into the urine, or demonstrated on antibody boost. It was concluded from the group variation that the antibody response was indeed due to the engraftment of BMT, rather than to a direct effect of treatment with IVIG. Our results further indicate that passive immunization with HCMV antibody does not prevent infection, but confers some protection against symptomatic disease.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 50 条
  • [41] PREDICTORS OF ACUTE RESPIRATORY-FAILURE AFTER BONE-MARROW TRANSPLANTATION IN CHILDREN
    NICHOLS, DG
    WALKER, LK
    WINGARD, JR
    BENDER, KS
    BEZMAN, M
    ZAHURAK, ML
    PIANTADOSI, S
    FREYSIMON, M
    ROGERS, MC
    CRITICAL CARE MEDICINE, 1994, 22 (09) : 1485 - 1491
  • [42] Cytomegalovirus gB Genotype Distribution in Mexican Children Undergoing Allogeneic Bone Marrow Transplantation
    Gonzalez-Ramirez, Javier
    Uribe-Gutierrez, Gabriel
    Jimenez-Hernandez, Elva
    Velazquez-Guadarrama, Norma
    Bello-Gonzalez, Abel
    Vazquez-Meraz, Eugenio
    Arellano-Galindo, Jose
    INTERVIROLOGY, 2012, 55 (04) : 318 - 320
  • [43] BONE-MARROW TRANSPLANTATION FOR THALASSEMIA - THE USA EXPERIENCE
    WALTERS, MC
    THOMAS, ED
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1994, 16 (01): : 11 - 17
  • [44] BONE-MARROW TRANSPLANTATION FOR ACUTE NONLYMPHOBLASTIC LEUKEMIA
    LJUNGMAN, P
    GAHRTON, G
    LEUKEMIA & LYMPHOMA, 1992, 7 (1-2) : 7 - 14
  • [45] CATARACT FORMATION AFTER BONE-MARROW TRANSPLANTATION
    TICHELLI, A
    GRATWOHL, A
    EGGER, T
    ROTH, J
    PRUNTE, A
    NISSEN, C
    SPECK, B
    ANNALS OF INTERNAL MEDICINE, 1993, 119 (12) : 1175 - 1180
  • [46] LATE COMPLICATIONS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION
    BACIGALUPO, A
    VANLINT, MT
    FRASSONI, F
    OCCHINI, D
    GUALANDI, F
    LAMPARELLI, T
    MARMONT, AM
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1991, 8 (04): : 261 - 263
  • [47] PSYCHOLOGICAL ISSUES FOLLOWING BONE-MARROW TRANSPLANTATION
    SOUSSAIN, C
    AMIELLEBIGRE, F
    BULLETIN DU CANCER, 1992, 79 (12) : 1135 - 1148
  • [48] INTRACRANIAL HEMATOMAS FOLLOWING BONE-MARROW TRANSPLANTATION
    POMERANZ, S
    NAPARSTEK, E
    ASHKENAZI, E
    NAGLER, A
    LOSSOS, A
    SLAVIN, S
    OR, R
    JOURNAL OF NEUROLOGY, 1994, 241 (04) : 252 - 256
  • [49] IMMUNE RECONSTITUTION FOLLOWING BONE-MARROW TRANSPLANTATION
    VERMA, UN
    MAZUMDER, A
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 37 (06) : 351 - 360
  • [50] MALASSEZIA FUNGEMIA AFTER BONE-MARROW TRANSPLANTATION
    SCHOEPFER, C
    CARLA, H
    BEZOU, MJ
    CAMBON, M
    GIRAULT, D
    DEMEOCQ, F
    MALPUECH, G
    ARCHIVES DE PEDIATRIE, 1995, 2 (03): : 245 - 248